PNC Financial Services Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
3,238
+73
+2% +$33.7K ﹤0.01% 1126
2026
Q1
$1.52M Sell
3,165
-102
-3% -$52.2K ﹤0.01% 1113
2025
Q4
$1.83M Sell
3,267
-327
-9% -$186K ﹤0.01% 1005
2025
Q3
$1.85M Sell
3,594
-52
-1% -$22.7K ﹤0.01% 984
2025
Q2
$1.14M Buy
3,646
+4
+0.1% +$1.2K ﹤0.01% 1127
2025
Q1
$1.11M Sell
3,642
-26
-0.7% -$8.75K ﹤0.01% 1125
2024
Q4
$1.22M Sell
3,668
-1,049
-22% -$356K ﹤0.01% 1088
2024
Q3
$1.57M Sell
4,717
-646
-12% -$245K ﹤0.01% 1004
2024
Q2
$2.21M Sell
5,363
-1,546
-22% -$612K ﹤0.01% 869
2024
Q1
$2.79M Sell
6,909
-1,841
-21% -$647K ﹤0.01% 801
2023
Q4
$2.68M Buy
8,750
+488
+6% +$132K ﹤0.01% 792
2023
Q3
$2M Sell
8,262
-1,090
-12% -$279K ﹤0.01% 853
2023
Q2
$2.25M Buy
9,352
+433
+5% +$89.9K ﹤0.01% 851
2023
Q1
$1.68M Sell
8,919
-103
-1% -$21.3K ﹤0.01% 929
2022
Q4
$1.92M Sell
9,022
-1,189
-12% -$238K ﹤0.01% 888
2022
Q3
$1.6M Sell
10,211
-1,900
-16% -$303K ﹤0.01% 932
2022
Q2
$1.81M Buy
12,111
+1,477
+14% +$214K ﹤0.01% 927
2022
Q1
$1.74M Sell
10,634
-730
-6% -$120K ﹤0.01% 993
2021
Q4
$2.47M Sell
11,364
-2,982
-21% -$624K ﹤0.01% 899
2021
Q3
$2.71M Buy
14,346
+290
+2% +$52.9K ﹤0.01% 819
2021
Q2
$2.48M Buy
14,056
+532
+4% +$91.8K ﹤0.01% 844
2021
Q1
$2.22M Buy
13,524
+627
+5% +$95.9K ﹤0.01% 844
2020
Q4
$1.79M Buy
12,897
+750
+6% +$94.5K ﹤0.01% 879
2020
Q3
$1.36M Buy
12,147
+482
+4% +$55.7K ﹤0.01% 927
2020
Q2
$1.08M Sell
11,665
-6,175
-35% -$525K ﹤0.01% 1004
2020
Q1
$1.31M Sell
17,840
-5,833
-25% -$506K ﹤0.01% 865
2019
Q4
$1.99M Sell
23,673
-109,916
-82% -$8.51M ﹤0.01% 814
2019
Q3
$11.2M Sell
133,589
-120,012
-47% -$9.07M 0.01% 460
2019
Q2
$16.6M Sell
253,601
-152,403
-38% -$8.78M 0.02% 412
2019
Q1
$23.9M Buy
406,004
+120,340
+42% +$7.19M 0.02% 351
2018
Q4
$15.1M Buy
285,664
+244,595
+596% +$13.4M 0.02% 405
2018
Q3
$2.46M Sell
41,069
-13,729
-25% -$751K ﹤0.01% 1005
2018
Q2
$2.36M Buy
54,798
+46,890
+593% +$1.89M ﹤0.01% 984
2018
Q1
$277K Sell
7,908
-2,382
-23% -$87K ﹤0.01% 1980
2017
Q4
$374K Buy
10,290
+7,895
+330% +$277K ﹤0.01% 1815
2017
Q3
$77K Buy
2,395
+995
+71% +$30.4K ﹤0.01% 2672
2017
Q2
$41K Hold
1,400
﹤0.01% 3008
2017
Q1
$42K Buy
1,400
+300
+27% +$9.68K ﹤0.01% 2962
2016
Q4
$40K Hold
1,100
﹤0.01% 2940
2016
Q3
$33K Buy
+1,100
New +$32.1K ﹤0.01% 3011

Other funds holding MEDP

PNC Financial Services Group's MEDP Position: Q2 2026 in Review

PNC Financial Services Group increased its Medpace (MEDP) stake by 2.3% in Q2 2026, buying an estimated $33.7K and bringing the position to 3,238 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

PNC Financial Services Group first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $23.9M in Q1 2019. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • PNC Financial Services Group held 3,238 shares of Medpace worth $1.71M as of Q2 2026.
  • PNC Financial Services Group bought 73 Medpace shares in Q2 2026, an estimated $33.7K.
  • Medpace made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1126 holding.
  • PNC Financial Services Group first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
  • PNC Financial Services Group's Medpace position peaked at $23.9M in Q1 2019.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.